← All Renalytix PLC filings

Renalytix PLC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OQB
RNLXY
Renalytix PLC
10-Q: Renalytix Reports Q1 2025 Results, Highlights Cost Reductions and Strategic Shift
Renalytix's Q1 2025 report shows a decrease in net loss and operating expenses, alongside a strategic shift towards commercial sales activities and a recent capital raise.
OQB
RNLXY
Renalytix PLC
10-Q: Renalytix Reports Q3 2024 Results Amid Strategic Review and Cost-Cutting Measures
Renalytix's Q3 2024 results show a decrease in revenue and ongoing losses, alongside significant cost reductions and a strategic review process.
OQB
RNLXY
Renalytix PLC
10-Q: Renalytix Reports Q2 2024 Results, Faces Nasdaq Compliance Challenges Amidst Cost-Cutting Efforts
Renalytix reports a decrease in revenue and increased net losses for the second quarter of fiscal year 2024, while also addressing Nasdaq compliance issues and implementing cost reduction measures.